Health Care and Life Sciences Companies Should Prioritize Corporate Compliance
A recent program sponsored by the Seton Hall Law Center for Health and Pharmaceutical Law & Policy urged health care and life sciences companies to place a high degree of emphasis on developing and...
View ArticleACI Presents: FCPA and Anti-Corruption for Life Science Companies
We are pleased this morning to refer you to what should be an outstanding event being put on by the American Conference Institute. The event is called “FCPA and Anti-Corruption for Life Science...
View ArticleTop Five Compliance Risks Facing Life Sciences Companies
[Editor's note: This article was originally published on November 18th, 2009.] ———- By Scott Bruns and Kathleen Meriwether of Ernst & Young It is difficult to adequately describe the risks facing...
View Article
More Pages to Explore .....